Lupin Ltd is the pharmaceutical company that has to foray into diagnostics to leverage its ‘doctor connect to tap a sector that has low entry barriers, gives high returns on capital employed, and is witnessing double-digit growth. A formal launch is expected next month, media reported.

• India Successfully Flight Tests Surface-to-air Missile
• Arkade Developers Ltd IPO GMP, Open/Close Date, Lot Size, and Price
• HCL Tech Completes Acquisition of Paris-based Zeenea
• SpaceX Made History with the First-Ever Civilian Spacewalk
• India’s Economic Relationship with China “Unfair”, Lacking Balance: Jaishankar

Lupin Diagnostics will be a part of Lupin Healthcare, a 100 per cent subsidiary of Lupin. It is in the process of recruiting the team, finalising franchise partners, and setting up a 45,000 square feet laboratory in Navi Mumbai.

Stock Covered in the news

Lupin Ltd- View Detailed Analysis